Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by Keeleron Apr 11, 2024 11:47pm
473 Views
Post# 35984827

You can listen to biased, misleading no substance

You can listen to biased, misleading no substancefrom Tilray's slanted 'team' - or you can do some actual research and take the overwhelmingly negative opinions of Tilrays performance, in other words - reality




Tilray Earnings: Slower Revenue Growth and Margin Contraction

We’ve lowered our fair value estimate of Tilray’s stock.

Key Morningstar Metrics for Tilray Brands

What We Thought of Tilray Brands’ Earnings

Tilray Brands TLRY issued disappointing results for the fiscal third quarter (February-ended) of 2024, including slower revenue growth and margin contraction. Changes to our forecast alone imply a valuation reduction roughly in line with the ensuing market price decline of about 21%. In addition, we’ve removed all contributions to our fair value estimate from Tilray’s ownership of US multistate operator Medmen’s senior secured convertible notes, as a complete write-off of the investment seems inevitable. The asset had made up about 20% of our fair value estimate.

Due to these factors, we are cutting our fair value estimate to $2. As reflected in our Very High Uncertainty Rating, changes to our forecast can have dramatic effects on our fair value estimates, especially as Tilray has yet to achieve positive free cash flow. Shares trade close to our updated fair value estimates.

Tilray reported net revenue of $188 million in the quarter, down 3% sequentially. The third quarter tends to be weak because of fewer cannabis and alcohol purchases during the winter. Still, the 5% sequential decline in cannabis revenue included some lost market share and price compression, driving us to lower our fiscal 2024 net revenue forecast to $755 million from $783 million and our adjusted EBITDA forecast to $60.5 million from $72.6 million.


<< Previous
Bullboard Posts
Next >>